
### [MONDO:0000589](http://purl.obolibrary.org/obo/MONDO_0000589)
**Label:** autoimmune disease of musculoskeletal system

**Subclasses:** [MONDO:0019559](http://purl.obolibrary.org/obo/MONDO_0019559) (hypertrophic or verrucous lupus erythematosus), [MONDO:0012361](http://purl.obolibrary.org/obo/MONDO_0012361) (SLEB5), [MONDO:0001907](http://purl.obolibrary.org/obo/MONDO_0001907) (adult dermatomyositis), [MONDO:0019557](http://purl.obolibrary.org/obo/MONDO_0019557) (Chilblain lupus), [MONDO:0019436](http://purl.obolibrary.org/obo/MONDO_0019436) (psoriasis-related juvenile idiopathic arthritis), [MONDO:0019437](http://purl.obolibrary.org/obo/MONDO_0019437) (Enthesitis-related juvenile idiopathic arthritis), [MONDO:0008383](http://purl.obolibrary.org/obo/MONDO_0008383) (rheumatoid arthritis), [MONDO:0019558](http://purl.obolibrary.org/obo/MONDO_0019558) (discoid lupus erythematosus), [MONDO:0017376](http://purl.obolibrary.org/obo/MONDO_0017376) (reactive arthritis), [MONDO:0019434](http://purl.obolibrary.org/obo/MONDO_0019434) (systemic-onset juvenile idiopathic arthritis), [MONDO:0019555](http://purl.obolibrary.org/obo/MONDO_0019555) (panniculitis and localized lipodystrophy), [MONDO:0019435](http://purl.obolibrary.org/obo/MONDO_0019435) (rheumatoid factor-positive polyarticular juvenile idiopathic arthritis), [MONDO:0008143](http://purl.obolibrary.org/obo/MONDO_0008143) (osteoarthritis susceptibility 1), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0005306](http://purl.obolibrary.org/obo/MONDO_0005306) (ankylosing spondylitis), [MONDO:0007603](http://purl.obolibrary.org/obo/MONDO_0007603) (Felty's syndrome), [MONDO:0006632](http://purl.obolibrary.org/obo/MONDO_0006632) (osteoarthritis, hand), [MONDO:0006631](http://purl.obolibrary.org/obo/MONDO_0006631) (osteoarthritis, toe), [MONDO:0013739](http://purl.obolibrary.org/obo/MONDO_0013739) (Chilblain lupus 2), [MONDO:0006630](http://purl.obolibrary.org/obo/MONDO_0006630) (osteoarthritis, spine), [MONDO:0014945](http://purl.obolibrary.org/obo/MONDO_0014945) (myopathy, distal, with rimmed vacuoles; DMRV), [MONDO:0012403](http://purl.obolibrary.org/obo/MONDO_0012403) (SLEB7), [MONDO:0007320](http://purl.obolibrary.org/obo/MONDO_0007320) (chondrocalcinosis due to Apatite crystal deposition), [MONDO:0012369](http://purl.obolibrary.org/obo/MONDO_0012369) (SLEB6), [MONDO:0016609](http://purl.obolibrary.org/obo/MONDO_0016609) (inflammatory myopathy with abundant macrophages), [MONDO:0012884](http://purl.obolibrary.org/obo/MONDO_0012884) (SLEB13), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0012404](http://purl.obolibrary.org/obo/MONDO_0012404) (SLEB8), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), [MONDO:0019789](http://purl.obolibrary.org/obo/MONDO_0019789) (cytophagic histiocytic panniculitis), [MONDO:0018456](http://purl.obolibrary.org/obo/MONDO_0018456) (polyarticular juvenile idiopathic arthritis), [MONDO:0008418](http://purl.obolibrary.org/obo/MONDO_0008418) (scleroderma, familial progressive), [MONDO:0005554](http://purl.obolibrary.org/obo/MONDO_0005554) (rheumatologic disorder), [MONDO:0011429](http://purl.obolibrary.org/obo/MONDO_0011429) (juvenile rheumatoid arthritis), [MONDO:0002047](http://purl.obolibrary.org/obo/MONDO_0002047) (pulmonary systemic sclerosis), [MONDO:0005393](http://purl.obolibrary.org/obo/MONDO_0005393) (gout), [MONDO:0011944](http://purl.obolibrary.org/obo/MONDO_0011944) (SLEN3), [MONDO:0011943](http://purl.obolibrary.org/obo/MONDO_0011943) (SLEN2), [MONDO:0011942](http://purl.obolibrary.org/obo/MONDO_0011942) (SLEN1), [MONDO:0018845](http://purl.obolibrary.org/obo/MONDO_0018845) (focal myositis), [MONDO:0009175](http://purl.obolibrary.org/obo/MONDO_0009175) (eosinophilic fasciitis (disease)), [MONDO:0013152](http://purl.obolibrary.org/obo/MONDO_0013152) (SLEB14), [MONDO:0015574](http://purl.obolibrary.org/obo/MONDO_0015574) (chronic cutaneous lupus erythematosus), [MONDO:0012584](http://purl.obolibrary.org/obo/MONDO_0012584) (systemic lupus erythematosus, susceptibility to, 9), [MONDO:0015573](http://purl.obolibrary.org/obo/MONDO_0015573) (subacute cutaneous lupus erythematosus), [MONDO:0020122](http://purl.obolibrary.org/obo/MONDO_0020122) (idiopathic inflammatory myopathy), [MONDO:0003627](http://purl.obolibrary.org/obo/MONDO_0003627) (rheumatic pulmonary valve disease), [MONDO:0007704](http://purl.obolibrary.org/obo/MONDO_0007704) (osteoarthritis susceptibility 2), [MONDO:0005403](http://purl.obolibrary.org/obo/MONDO_0005403) (neonatal systemic lupus erthematosus), [MONDO:0006611](http://purl.obolibrary.org/obo/MONDO_0006611) (skin sarcoidosis), [MONDO:0004670](http://purl.obolibrary.org/obo/MONDO_0004670) (lupus erythematosus), [MONDO:0011138](http://purl.obolibrary.org/obo/MONDO_0011138) (systemic lupus erythematosus, susceptibility to, 1), [MONDO:0012500](http://purl.obolibrary.org/obo/MONDO_0012500) (Chilblain lupus 1), [MONDO:0016099](http://purl.obolibrary.org/obo/MONDO_0016099) (overlap myositis), [MONDO:0019127](http://purl.obolibrary.org/obo/MONDO_0019127) (polymyositis), [MONDO:0019125](http://purl.obolibrary.org/obo/MONDO_0019125) (relapsing polychondritis), [MONDO:0016098](http://purl.obolibrary.org/obo/MONDO_0016098) (immune-mediated necrotizing myopathy), [MONDO:0006629](http://purl.obolibrary.org/obo/MONDO_0006629) (osteoarthritis, hip), [MONDO:0005019](http://purl.obolibrary.org/obo/MONDO_0005019) (diffuse scleroderma), [MONDO:0007319](http://purl.obolibrary.org/obo/MONDO_0007319) (familial calcium pyrophosphate deposition), [MONDO:0005416](http://purl.obolibrary.org/obo/MONDO_0005416) (osteoarthritis, knee), [MONDO:0011807](http://purl.obolibrary.org/obo/MONDO_0011807) (SLEH1), [MONDO:0010433](http://purl.obolibrary.org/obo/MONDO_0010433) (SLEB15), [MONDO:0005251](http://purl.obolibrary.org/obo/MONDO_0005251) (pauciarticular juvenile rheumatoid arthritis), [MONDO:0011520](http://purl.obolibrary.org/obo/MONDO_0011520) (systemic lupus erythematosus, susceptibility to, 2), [MONDO:0011923](http://purl.obolibrary.org/obo/MONDO_0011923) (osteoarthritis susceptibility 3), [MONDO:0016367](http://purl.obolibrary.org/obo/MONDO_0016367) (dermatomyositis), [MONDO:0001709](http://purl.obolibrary.org/obo/MONDO_0001709) (hypercalcemic sarcoidosis), [MONDO:0001706](http://purl.obolibrary.org/obo/MONDO_0001706) (cerebral sarcoidosis), [MONDO:0019355](http://purl.obolibrary.org/obo/MONDO_0019355) (adult-onset Still disease), [MONDO:0001708](http://purl.obolibrary.org/obo/MONDO_0001708) (pulmonary sarcoidosis), [MONDO:0001707](http://purl.obolibrary.org/obo/MONDO_0001707) (cardiac sarcoidosis), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0001424](http://purl.obolibrary.org/obo/MONDO_0001424) (sarcoid meningitis), [MONDO:0006832](http://purl.obolibrary.org/obo/MONDO_0006832) (limited scleroderma), [MONDO:0005100](http://purl.obolibrary.org/obo/MONDO_0005100) (systemic scleroderma), [MONDO:0005185](http://purl.obolibrary.org/obo/MONDO_0005185) (chronic childhood arthritis), [MONDO:0012568](http://purl.obolibrary.org/obo/MONDO_0012568) (OS4), [MONDO:0018827](http://purl.obolibrary.org/obo/MONDO_0018827) (familial Chilblain lupus), [MONDO:0016356](http://purl.obolibrary.org/obo/MONDO_0016356) (diffuse cutaneous systemic sclerosis), [MONDO:0016359](http://purl.obolibrary.org/obo/MONDO_0016359) (limited systemic sclerosis), [MONDO:0016358](http://purl.obolibrary.org/obo/MONDO_0016358) (limited cutaneous systemic sclerosis), [MONDO:0008054](http://purl.obolibrary.org/obo/MONDO_0008054) (juvenile dermatomyositis), [MONDO:0016474](http://purl.obolibrary.org/obo/MONDO_0016474) (drug-induced lupus erythematosus), [MONDO:0012036](http://purl.obolibrary.org/obo/MONDO_0012036) (SLEB4), [MONDO:0019344](http://purl.obolibrary.org/obo/MONDO_0019344) (Antisynthetase syndrome), [MONDO:0018011](http://purl.obolibrary.org/obo/MONDO_0018011) (juvenile overlap myositis), [MONDO:0018010](http://purl.obolibrary.org/obo/MONDO_0018010) (juvenile idiopathic inflammatory myopathy), [MONDO:0001314](http://purl.obolibrary.org/obo/MONDO_0001314) (chondrocalcinosis), [MONDO:0007011](http://purl.obolibrary.org/obo/MONDO_0007011) (uveoparotid fever), [MONDO:0012836](http://purl.obolibrary.org/obo/MONDO_0012836) (SLEB12), [MONDO:0012835](http://purl.obolibrary.org/obo/MONDO_0012835) (systemic lupus erythematosus, susceptibility to, 11), [MONDO:0012834](http://purl.obolibrary.org/obo/MONDO_0012834) (systemic lupus erythematosus, susceptibility to, 10), [MONDO:0019735](http://purl.obolibrary.org/obo/MONDO_0019735) (polymyalgia rheumatica), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0018887](http://purl.obolibrary.org/obo/MONDO_0018887) (rare cutaneous lupus erythematosus), [MONDO:0019734](http://purl.obolibrary.org/obo/MONDO_0019734) (juvenile polymyositis), [MONDO:0018360](http://purl.obolibrary.org/obo/MONDO_0018360) (neonatal lupus erythematosus), [MONDO:0006898](http://purl.obolibrary.org/obo/MONDO_0006898) (periarthritis), [MONDO:0004471](http://purl.obolibrary.org/obo/MONDO_0004471) (septic arthritis), [MONDO:0005282](http://purl.obolibrary.org/obo/MONDO_0005282) (cutaneous lupus erythematosus), [MONDO:0016610](http://purl.obolibrary.org/obo/MONDO_0016610) (idiopathic eosinophilic myositis), [MONDO:0012894](http://purl.obolibrary.org/obo/MONDO_0012894) (OS6), [MONDO:0012893](http://purl.obolibrary.org/obo/MONDO_0012893) (osteoarthritis susceptibility 5), [MONDO:0019564](http://purl.obolibrary.org/obo/MONDO_0019564) (systemic sclerosis), [MONDO:0002906](http://purl.obolibrary.org/obo/MONDO_0002906) (scleroderma), [MONDO:0011560](http://purl.obolibrary.org/obo/MONDO_0011560) (SLEB3), [MONDO:0019562](http://purl.obolibrary.org/obo/MONDO_0019562) (localized scleroderma), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0019563](http://purl.obolibrary.org/obo/MONDO_0019563) (crest syndrome), [MONDO:0019560](http://purl.obolibrary.org/obo/MONDO_0019560) (lupus erythematosus tumidus), [MONDO:0019561](http://purl.obolibrary.org/obo/MONDO_0019561) (lupus erythematosus panniculitis), [MONDO:0007915](http://purl.obolibrary.org/obo/MONDO_0007915) (systemic lupus erythematosus (disease)), [MONDO:0005578](http://purl.obolibrary.org/obo/MONDO_0005578) (arthritis), [MONDO:0005854](http://purl.obolibrary.org/obo/MONDO_0005854) (mixed connective tissue disease), [MONDO:0011849](http://purl.obolibrary.org/obo/MONDO_0011849) (psoriatic arthritis), [MONDO:0005178](http://purl.obolibrary.org/obo/MONDO_0005178) (osteoarthritis), [MONDO:0010917](http://purl.obolibrary.org/obo/MONDO_0010917) (CCAL1), [MONDO:0016618](http://purl.obolibrary.org/obo/MONDO_0016618) (rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0016617](http://purl.obolibrary.org/obo/MONDO_0016617) (rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies), [MONDO:0019607](http://purl.obolibrary.org/obo/MONDO_0019607) (unspecified juvenile idiopathic arthritis), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), [MONDO:0013743](http://purl.obolibrary.org/obo/MONDO_0013743) (autosomal systemic lupus erythematosus), [MONDO:0016616](http://purl.obolibrary.org/obo/MONDO_0016616) (Oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0016615](http://purl.obolibrary.org/obo/MONDO_0016615) (Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies), 

**Mapped go classes:** [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity), [GO:2000483](http://purl.obolibrary.org/obo/GO_2000483) (negative regulation of interleukin-8 secretion), [GO:1901222](http://purl.obolibrary.org/obo/GO_1901222) (regulation of NIK/NF-kappaB signaling), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0004540](http://purl.obolibrary.org/obo/GO_0004540) (ribonuclease activity), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0004536](http://purl.obolibrary.org/obo/GO_0004536) (deoxyribonuclease activity), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0006959](http://purl.obolibrary.org/obo/GO_0006959) (humoral immune response), [GO:0046061](http://purl.obolibrary.org/obo/GO_0046061) (dATP catabolic process), [GO:0050798](http://purl.obolibrary.org/obo/GO_0050798) (activated T cell proliferation), [GO:0036122](http://purl.obolibrary.org/obo/GO_0036122) (BMP binding), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0060591](http://purl.obolibrary.org/obo/GO_0060591) (chondroblast differentiation), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0002253](http://purl.obolibrary.org/obo/GO_0002253) (activation of immune response), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0004668](http://purl.obolibrary.org/obo/GO_0004668) (protein-arginine deiminase activity), [GO:0005518](http://purl.obolibrary.org/obo/GO_0005518) (collagen binding), [GO:0097413](http://purl.obolibrary.org/obo/GO_0097413) (Lewy body), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:2000363](http://purl.obolibrary.org/obo/GO_2000363) (positive regulation of prostaglandin-E synthase activity), [GO:2000484](http://purl.obolibrary.org/obo/GO_2000484) (positive regulation of interleukin-8 secretion), [GO:0051898](http://purl.obolibrary.org/obo/GO_0051898) (negative regulation of protein kinase B signaling), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0015651](http://purl.obolibrary.org/obo/GO_0015651) (quaternary ammonium group transmembrane transporter activity), [GO:1900273](http://purl.obolibrary.org/obo/GO_1900273) (positive regulation of long-term synaptic potentiation), [GO:0004520](http://purl.obolibrary.org/obo/GO_0004520) (endodeoxyribonuclease activity), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0060029](http://purl.obolibrary.org/obo/GO_0060029) (convergent extension involved in organogenesis), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006814](http://purl.obolibrary.org/obo/GO_0006814) (sodium ion transport), [GO:0004875](http://purl.obolibrary.org/obo/GO_0004875) (complement receptor activity), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:1905719](http://purl.obolibrary.org/obo/GO_1905719) (protein localization to perinuclear region of cytoplasm), [GO:0006817](http://purl.obolibrary.org/obo/GO_0006817) (phosphate ion transport), [GO:0071157](http://purl.obolibrary.org/obo/GO_0071157) (negative regulation of cell cycle arrest), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0016990](http://purl.obolibrary.org/obo/GO_0016990) (arginine deiminase activity), [GO:0035136](http://purl.obolibrary.org/obo/GO_0035136) (forelimb morphogenesis), [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0060376](http://purl.obolibrary.org/obo/GO_0060376) (positive regulation of mast cell differentiation), [GO:1900042](http://purl.obolibrary.org/obo/GO_1900042) (positive regulation of interleukin-2 secretion), [GO:0034165](http://purl.obolibrary.org/obo/GO_0034165) (positive regulation of toll-like receptor 9 signaling pathway), [GO:1900165](http://purl.obolibrary.org/obo/GO_1900165) (negative regulation of interleukin-6 secretion), [GO:0060252](http://purl.obolibrary.org/obo/GO_0060252) (positive regulation of glial cell proliferation), [GO:1904646](http://purl.obolibrary.org/obo/GO_1904646) (cellular response to amyloid-beta), [GO:0002230](http://purl.obolibrary.org/obo/GO_0002230) (positive regulation of defense response to virus by host), [GO:0006952](http://purl.obolibrary.org/obo/GO_0006952) (defense response), [GO:0004530](http://purl.obolibrary.org/obo/GO_0004530) (deoxyribonuclease I activity), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0004527](http://purl.obolibrary.org/obo/GO_0004527) (exonuclease activity), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0034157](http://purl.obolibrary.org/obo/GO_0034157) (positive regulation of toll-like receptor 7 signaling pathway), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0015114](http://purl.obolibrary.org/obo/GO_0015114) (phosphate ion transmembrane transporter activity), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0048680](http://purl.obolibrary.org/obo/GO_0048680) (positive regulation of axon regeneration), [GO:0030504](http://purl.obolibrary.org/obo/GO_0030504) (inorganic diphosphate transmembrane transporter activity), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0070367](http://purl.obolibrary.org/obo/GO_0070367) (negative regulation of hepatocyte differentiation), [GO:0071219](http://purl.obolibrary.org/obo/GO_0071219) (cellular response to molecule of bacterial origin), [GO:0015226](http://purl.obolibrary.org/obo/GO_0015226) (carnitine transmembrane transporter activity), [GO:0030500](http://purl.obolibrary.org/obo/GO_0030500) (regulation of bone mineralization), [GO:0019827](http://purl.obolibrary.org/obo/GO_0019827) (stem cell population maintenance), [GO:0014033](http://purl.obolibrary.org/obo/GO_0014033) (neural crest cell differentiation), [GO:1902523](http://purl.obolibrary.org/obo/GO_1902523) (positive regulation of protein K63-linked ubiquitination), [GO:0006898](http://purl.obolibrary.org/obo/GO_0006898) (receptor-mediated endocytosis), [GO:0008832](http://purl.obolibrary.org/obo/GO_0008832) (dGTPase activity), [GO:0005315](http://purl.obolibrary.org/obo/GO_0005315) (inorganic phosphate transmembrane transporter activity), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0050765](http://purl.obolibrary.org/obo/GO_0050765) (negative regulation of phagocytosis), [GO:0015698](http://purl.obolibrary.org/obo/GO_0015698) (inorganic anion transport), [GO:0015697](http://purl.obolibrary.org/obo/GO_0015697) (quaternary ammonium group transport), [GO:1903980](http://purl.obolibrary.org/obo/GO_1903980) (positive regulation of microglial cell activation), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0005776](http://purl.obolibrary.org/obo/GO_0005776) (autophagosome), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0016793](http://purl.obolibrary.org/obo/GO_0016793) (triphosphoric monoester hydrolase activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0050777](http://purl.obolibrary.org/obo/GO_0050777) (negative regulation of immune response), [GO:0050778](http://purl.obolibrary.org/obo/GO_0050778) (positive regulation of immune response), [GO:0050776](http://purl.obolibrary.org/obo/GO_0050776) (regulation of immune response), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0015101](http://purl.obolibrary.org/obo/GO_0015101) (organic cation transmembrane transporter activity), [GO:1903753](http://purl.obolibrary.org/obo/GO_1903753) (negative regulation of p38MAPK cascade), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:1901216](http://purl.obolibrary.org/obo/GO_1901216) (positive regulation of neuron death), [GO:0002035](http://purl.obolibrary.org/obo/GO_0002035) (brain renin-angiotensin system), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0045088](http://purl.obolibrary.org/obo/GO_0045088) (regulation of innate immune response), [GO:0071225](http://purl.obolibrary.org/obo/GO_0071225) (cellular response to muramyl dipeptide), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0050787](http://purl.obolibrary.org/obo/GO_0050787) (detoxification of mercury ion), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0014005](http://purl.obolibrary.org/obo/GO_0014005) (microglia development), [GO:2001054](http://purl.obolibrary.org/obo/GO_2001054) (negative regulation of mesenchymal cell apoptotic process), [GO:0043508](http://purl.obolibrary.org/obo/GO_0043508) (negative regulation of JUN kinase activity), [GO:0061053](http://purl.obolibrary.org/obo/GO_0061053) (somite development), [GO:0006325](http://purl.obolibrary.org/obo/GO_0006325) (chromatin organization), [GO:0006203](http://purl.obolibrary.org/obo/GO_0006203) (dGTP catabolic process), [GO:0042535](http://purl.obolibrary.org/obo/GO_0042535) (positive regulation of tumor necrosis factor biosynthetic process), [GO:0097242](http://purl.obolibrary.org/obo/GO_0097242) (amyloid-beta clearance), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0032729](http://purl.obolibrary.org/obo/GO_0032729) (positive regulation of interferon-gamma production), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0043518](http://purl.obolibrary.org/obo/GO_0043518) (negative regulation of DNA damage response, signal transduction by p53 class mediator), [GO:1902166](http://purl.obolibrary.org/obo/GO_1902166) (negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0008514](http://purl.obolibrary.org/obo/GO_0008514) (organic anion transmembrane transporter activity), [GO:0006334](http://purl.obolibrary.org/obo/GO_0006334) (nucleosome assembly), [GO:0005126](http://purl.obolibrary.org/obo/GO_0005126) (cytokine receptor binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0030890](http://purl.obolibrary.org/obo/GO_0030890) (positive regulation of B cell proliferation), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0019752](http://purl.obolibrary.org/obo/GO_0019752) (carboxylic acid metabolic process), [GO:0061078](http://purl.obolibrary.org/obo/GO_0061078) (positive regulation of prostaglandin secretion involved in immune response), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:0045947](http://purl.obolibrary.org/obo/GO_0045947) (negative regulation of translational initiation), [GO:0040011](http://purl.obolibrary.org/obo/GO_0040011) (locomotion), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0015491](http://purl.obolibrary.org/obo/GO_0015491) (cation:cation antiporter activity), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0044853](http://purl.obolibrary.org/obo/GO_0044853) (plasma membrane raft), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0045821](http://purl.obolibrary.org/obo/GO_0045821) (positive regulation of glycolytic process), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0050178](http://purl.obolibrary.org/obo/GO_0050178) (phenylpyruvate tautomerase activity), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0030889](http://purl.obolibrary.org/obo/GO_0030889) (negative regulation of B cell proliferation), [GO:0097225](http://purl.obolibrary.org/obo/GO_0097225) (sperm midpiece), [GO:0061081](http://purl.obolibrary.org/obo/GO_0061081) (positive regulation of myeloid leukocyte cytokine production involved in immune response), [GO:0016234](http://purl.obolibrary.org/obo/GO_0016234) (inclusion body), [GO:0019865](http://purl.obolibrary.org/obo/GO_0019865) (immunoglobulin binding), [GO:0016235](http://purl.obolibrary.org/obo/GO_0016235) (aggresome), [GO:0019864](http://purl.obolibrary.org/obo/GO_0019864) (IgG binding), [GO:0016236](http://purl.obolibrary.org/obo/GO_0016236) (macroautophagy), [GO:0016358](http://purl.obolibrary.org/obo/GO_0016358) (dendrite development), [GO:0042327](http://purl.obolibrary.org/obo/GO_0042327) (positive regulation of phosphorylation), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0008853](http://purl.obolibrary.org/obo/GO_0008853) (exodeoxyribonuclease III activity), [GO:0030513](http://purl.obolibrary.org/obo/GO_0030513) (positive regulation of BMP signaling pathway), [GO:0006308](http://purl.obolibrary.org/obo/GO_0006308) (DNA catabolic process), [GO:0032819](http://purl.obolibrary.org/obo/GO_0032819) (positive regulation of natural killer cell proliferation), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0032817](http://purl.obolibrary.org/obo/GO_0032817) (regulation of natural killer cell proliferation), [GO:0032930](http://purl.obolibrary.org/obo/GO_0032930) (positive regulation of superoxide anion generation), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:0015199](http://purl.obolibrary.org/obo/GO_0015199) (amino-acid betaine transmembrane transporter activity), [GO:0000932](http://purl.obolibrary.org/obo/GO_0000932) (P-body), [GO:0098780](http://purl.obolibrary.org/obo/GO_0098780) (response to mitochondrial depolarisation), [GO:0008305](http://purl.obolibrary.org/obo/GO_0008305) (integrin complex), [GO:0032407](http://purl.obolibrary.org/obo/GO_0032407) (MutSalpha complex binding), [GO:0010739](http://purl.obolibrary.org/obo/GO_0010739) (positive regulation of protein kinase A signaling), [GO:0032405](http://purl.obolibrary.org/obo/GO_0032405) (MutLalpha complex binding), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0033613](http://purl.obolibrary.org/obo/GO_0033613) (activating transcription factor binding), [GO:0005160](http://purl.obolibrary.org/obo/GO_0005160) (transforming growth factor beta receptor binding), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0005164](http://purl.obolibrary.org/obo/GO_0005164) (tumor necrosis factor receptor binding), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0006259](http://purl.obolibrary.org/obo/GO_0006259) (DNA metabolic process), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0030217](http://purl.obolibrary.org/obo/GO_0030217) (T cell differentiation), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010507](http://purl.obolibrary.org/obo/GO_0010507) (negative regulation of autophagy), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0018101](http://purl.obolibrary.org/obo/GO_0018101) (protein citrullination), [GO:0030330](http://purl.obolibrary.org/obo/GO_0030330) (DNA damage response, signal transduction by p53 class mediator), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:0010623](http://purl.obolibrary.org/obo/GO_0010623) (programmed cell death involved in cell development), [GO:0031666](http://purl.obolibrary.org/obo/GO_0031666) (positive regulation of lipopolysaccharide-mediated signaling pathway), [GO:0010862](http://purl.obolibrary.org/obo/GO_0010862) (positive regulation of pathway-restricted SMAD protein phosphorylation), [GO:0031665](http://purl.obolibrary.org/obo/GO_0031665) (negative regulation of lipopolysaccharide-mediated signaling pathway), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0042756](http://purl.obolibrary.org/obo/GO_0042756) (drinking behavior), [GO:0061037](http://purl.obolibrary.org/obo/GO_0061037) (negative regulation of cartilage development), [GO:0015293](http://purl.obolibrary.org/obo/GO_0015293) (symporter activity), [GO:0042993](http://purl.obolibrary.org/obo/GO_0042993) (positive regulation of transcription factor import into nucleus), [GO:0008761](http://purl.obolibrary.org/obo/GO_0008761) (UDP-N-acetylglucosamine 2-epimerase activity), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0004167](http://purl.obolibrary.org/obo/GO_0004167) (dopachrome isomerase activity), [GO:0005138](http://purl.obolibrary.org/obo/GO_0005138) (interleukin-6 receptor binding), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0098636](http://purl.obolibrary.org/obo/GO_0098636) (protein complex involved in cell adhesion), [GO:0017124](http://purl.obolibrary.org/obo/GO_0017124) (SH3 domain binding), [GO:0019546](http://purl.obolibrary.org/obo/GO_0019546) (arginine deiminase pathway), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:1905898](http://purl.obolibrary.org/obo/GO_1905898) (positive regulation of response to endoplasmic reticulum stress), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0008408](http://purl.obolibrary.org/obo/GO_0008408) (3'-5' exonuclease activity), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0019770](http://purl.obolibrary.org/obo/GO_0019770) (IgG receptor activity), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0010721](http://purl.obolibrary.org/obo/GO_0010721) (negative regulation of cell development), [GO:0019772](http://purl.obolibrary.org/obo/GO_0019772) (low-affinity IgG receptor activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0032693](http://purl.obolibrary.org/obo/GO_0032693) (negative regulation of interleukin-10 production), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0006047](http://purl.obolibrary.org/obo/GO_0006047) (UDP-N-acetylglucosamine metabolic process), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0009437](http://purl.obolibrary.org/obo/GO_0009437) (carnitine metabolic process), [GO:0001820](http://purl.obolibrary.org/obo/GO_0001820) (serotonin secretion), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0034987](http://purl.obolibrary.org/obo/GO_0034987) (immunoglobulin receptor binding), [GO:0032567](http://purl.obolibrary.org/obo/GO_0032567) (dGTP binding), [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding), [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging), [GO:0090103](http://purl.obolibrary.org/obo/GO_0090103) (cochlea morphogenesis), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0006054](http://purl.obolibrary.org/obo/GO_0006054) (N-acetylneuraminate metabolic process), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0034618](http://purl.obolibrary.org/obo/GO_0034618) (arginine binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0002924](http://purl.obolibrary.org/obo/GO_0002924) (negative regulation of humoral immune response mediated by circulating immunoglobulin), [GO:0002925](http://purl.obolibrary.org/obo/GO_0002925) (positive regulation of humoral immune response mediated by circulating immunoglobulin), [GO:0032558](http://purl.obolibrary.org/obo/GO_0032558) (adenyl deoxyribonucleotide binding), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0090314](http://purl.obolibrary.org/obo/GO_0090314) (positive regulation of protein targeting to membrane), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0043122](http://purl.obolibrary.org/obo/GO_0043122) (regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0005057](http://purl.obolibrary.org/obo/GO_0005057) (signal transducer activity, downstream of receptor), [GO:0038096](http://purl.obolibrary.org/obo/GO_0038096) (Fc-gamma receptor signaling pathway involved in phagocytosis), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0001805](http://purl.obolibrary.org/obo/GO_0001805) (positive regulation of type III hypersensitivity), [GO:0022857](http://purl.obolibrary.org/obo/GO_0022857) (transmembrane transporter activity), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0042288](http://purl.obolibrary.org/obo/GO_0042288) (MHC class I protein binding), [GO:0007249](http://purl.obolibrary.org/obo/GO_0007249) (I-kappaB kinase/NF-kappaB signaling), [GO:0042169](http://purl.obolibrary.org/obo/GO_0042169) (SH2 domain binding), [GO:0001811](http://purl.obolibrary.org/obo/GO_0001811) (negative regulation of type I hypersensitivity), [GO:0001812](http://purl.obolibrary.org/obo/GO_0001812) (positive regulation of type I hypersensitivity), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0002906](http://purl.obolibrary.org/obo/GO_0002906) (negative regulation of mature B cell apoptotic process), [GO:0010760](http://purl.obolibrary.org/obo/GO_0010760) (negative regulation of macrophage chemotaxis), [GO:0032494](http://purl.obolibrary.org/obo/GO_0032494) (response to peptidoglycan), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:1903169](http://purl.obolibrary.org/obo/GO_1903169) (regulation of calcium ion transmembrane transport), [GO:0032495](http://purl.obolibrary.org/obo/GO_0032495) (response to muramyl dipeptide), [GO:0045600](http://purl.obolibrary.org/obo/GO_0045600) (positive regulation of fat cell differentiation), [GO:0045963](http://purl.obolibrary.org/obo/GO_0045963) (negative regulation of dopamine metabolic process), [GO:0044753](http://purl.obolibrary.org/obo/GO_0044753) (amphisome), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0044754](http://purl.obolibrary.org/obo/GO_0044754) (autolysosome), [GO:0044877](http://purl.obolibrary.org/obo/GO_0044877) (macromolecular complex binding), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0007184](http://purl.obolibrary.org/obo/GO_0007184) (SMAD protein import into nucleus), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0042100](http://purl.obolibrary.org/obo/GO_0042100) (B cell proliferation), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0000423](http://purl.obolibrary.org/obo/GO_0000423) (mitophagy), [GO:0043315](http://purl.obolibrary.org/obo/GO_0043315) (positive regulation of neutrophil degranulation), [GO:0042590](http://purl.obolibrary.org/obo/GO_0042590) (antigen processing and presentation of exogenous peptide antigen via MHC class I), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0001516](http://purl.obolibrary.org/obo/GO_0001516) (prostaglandin biosynthetic process), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0043209](http://purl.obolibrary.org/obo/GO_0043209) (myelin sheath), [GO:0007032](http://purl.obolibrary.org/obo/GO_0007032) (endosome organization), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0042113](http://purl.obolibrary.org/obo/GO_0042113) (B cell activation), [GO:0007159](http://purl.obolibrary.org/obo/GO_0007159) (leukocyte cell-cell adhesion), [GO:0043330](http://purl.obolibrary.org/obo/GO_0043330) (response to exogenous dsRNA), [GO:0001846](http://purl.obolibrary.org/obo/GO_0001846) (opsonin binding), [GO:0030165](http://purl.obolibrary.org/obo/GO_0030165) (PDZ domain binding), [GO:0001848](http://purl.obolibrary.org/obo/GO_0001848) (complement binding), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0035973](http://purl.obolibrary.org/obo/GO_0035973) (aggrephagy), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0000407](http://purl.obolibrary.org/obo/GO_0000407) (phagophore assembly site), [GO:1903078](http://purl.obolibrary.org/obo/GO_1903078) (positive regulation of protein localization to plasma membrane), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0001851](http://purl.obolibrary.org/obo/GO_0001851) (complement component C3b binding), [GO:0002821](http://purl.obolibrary.org/obo/GO_0002821) (positive regulation of adaptive immune response), [GO:0042130](http://purl.obolibrary.org/obo/GO_0042130) (negative regulation of T cell proliferation), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0032331](http://purl.obolibrary.org/obo/GO_0032331) (negative regulation of chondrocyte differentiation), [GO:0032332](http://purl.obolibrary.org/obo/GO_0032332) (positive regulation of chondrocyte differentiation), [GO:0012501](http://purl.obolibrary.org/obo/GO_0012501) (programmed cell death), [GO:0032456](http://purl.obolibrary.org/obo/GO_0032456) (endocytic recycling), [GO:1902950](http://purl.obolibrary.org/obo/GO_1902950) (regulation of dendritic spine maintenance), [GO:1902715](http://purl.obolibrary.org/obo/GO_1902715) (positive regulation of interferon-gamma secretion), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0002876](http://purl.obolibrary.org/obo/GO_0002876) (positive regulation of chronic inflammatory response to antigenic stimulus), [GO:0001788](http://purl.obolibrary.org/obo/GO_0001788) (antibody-dependent cellular cytotoxicity), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0002638](http://purl.obolibrary.org/obo/GO_0002638) (negative regulation of immunoglobulin production), [GO:0050715](http://purl.obolibrary.org/obo/GO_0050715) (positive regulation of cytokine secretion), [GO:0070207](http://purl.obolibrary.org/obo/GO_0070207) (protein homotrimerization), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0035435](http://purl.obolibrary.org/obo/GO_0035435) (phosphate ion transmembrane transport), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0031072](http://purl.obolibrary.org/obo/GO_0031072) (heat shock protein binding), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0002523](http://purl.obolibrary.org/obo/GO_0002523) (leukocyte migration involved in inflammatory response), [GO:0001798](http://purl.obolibrary.org/obo/GO_0001798) (positive regulation of type IIa hypersensitivity), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0015838](http://purl.obolibrary.org/obo/GO_0015838) (amino-acid betaine transport), [GO:0035549](http://purl.obolibrary.org/obo/GO_0035549) (positive regulation of interferon-beta secretion), [GO:0070433](http://purl.obolibrary.org/obo/GO_0070433) (negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0048535](http://purl.obolibrary.org/obo/GO_0048535) (lymph node development), [GO:0060429](http://purl.obolibrary.org/obo/GO_0060429) (epithelium development), [GO:0061635](http://purl.obolibrary.org/obo/GO_0061635) (regulation of protein complex stability), [GO:0061756](http://purl.obolibrary.org/obo/GO_0061756) (leukocyte adhesion to vascular endothelial cell), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001887](http://purl.obolibrary.org/obo/GO_0001887) (selenium compound metabolic process), [GO:0071310](http://purl.obolibrary.org/obo/GO_0071310) (cellular response to organic substance), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0050856](http://purl.obolibrary.org/obo/GO_0050856) (regulation of T cell receptor signaling pathway), [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0050853](http://purl.obolibrary.org/obo/GO_0050853) (B cell receptor signaling pathway), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0008296](http://purl.obolibrary.org/obo/GO_0008296) (3'-5'-exodeoxyribonuclease activity), [GO:0009384](http://purl.obolibrary.org/obo/GO_0009384) (N-acylmannosamine kinase activity), [GO:1902741](http://purl.obolibrary.org/obo/GO_1902741) (positive regulation of interferon-alpha secretion), [GO:0001781](http://purl.obolibrary.org/obo/GO_0001781) (neutrophil apoptotic process), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:0001773](http://purl.obolibrary.org/obo/GO_0001773) (myeloid dendritic cell activation), [GO:0002862](http://purl.obolibrary.org/obo/GO_0002862) (negative regulation of inflammatory response to antigenic stimulus), [GO:0001774](http://purl.obolibrary.org/obo/GO_0001774) (microglial cell activation), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0002865](http://purl.obolibrary.org/obo/GO_0002865) (negative regulation of acute inflammatory response to antigenic stimulus), [GO:0071663](http://purl.obolibrary.org/obo/GO_0071663) (positive regulation of granzyme B production), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0050869](http://purl.obolibrary.org/obo/GO_0050869) (negative regulation of B cell activation), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0050868](http://purl.obolibrary.org/obo/GO_0050868) (negative regulation of T cell activation), [GO:0035644](http://purl.obolibrary.org/obo/GO_0035644) (phosphoanandamide dephosphorylation), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0016605](http://purl.obolibrary.org/obo/GO_0016605) (PML body), [GO:0042056](http://purl.obolibrary.org/obo/GO_0042056) (chemoattractant activity), [GO:0043268](http://purl.obolibrary.org/obo/GO_0043268) (positive regulation of potassium ion transport), [GO:0004860](http://purl.obolibrary.org/obo/GO_0004860) (protein kinase inhibitor activity), [GO:0002685](http://purl.obolibrary.org/obo/GO_0002685) (regulation of leukocyte migration), [GO:0002675](http://purl.obolibrary.org/obo/GO_0002675) (positive regulation of acute inflammatory response), [GO:0002434](http://purl.obolibrary.org/obo/GO_0002434) (immune complex clearance), [GO:0006910](http://purl.obolibrary.org/obo/GO_0006910) (phagocytosis, recognition), [GO:0006911](http://purl.obolibrary.org/obo/GO_0006911) (phagocytosis, engulfment), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0034141](http://purl.obolibrary.org/obo/GO_0034141) (positive regulation of toll-like receptor 3 signaling pathway), [GO:0034145](http://purl.obolibrary.org/obo/GO_0034145) (positive regulation of toll-like receptor 4 signaling pathway), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0045576](http://purl.obolibrary.org/obo/GO_0045576) (mast cell activation), [GO:0045334](http://purl.obolibrary.org/obo/GO_0045334) (clathrin-coated endocytic vesicle), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0002323](http://purl.obolibrary.org/obo/GO_0002323) (natural killer cell activation involved in immune response), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:2000566](http://purl.obolibrary.org/obo/GO_2000566) (positive regulation of CD8-positive, alpha-beta T cell proliferation), [GO:0015879](http://purl.obolibrary.org/obo/GO_0015879) (carnitine transport), [GO:0090238](http://purl.obolibrary.org/obo/GO_0090238) (positive regulation of arachidonic acid secretion), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0046677](http://purl.obolibrary.org/obo/GO_0046677) (response to antibiotic), [GO:0045345](http://purl.obolibrary.org/obo/GO_0045345) (positive regulation of MHC class I biosynthetic process), [GO:0045348](http://purl.obolibrary.org/obo/GO_0045348) (positive regulation of MHC class II biosynthetic process), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0045590](http://purl.obolibrary.org/obo/GO_0045590) (negative regulation of regulatory T cell differentiation), [GO:0046685](http://purl.obolibrary.org/obo/GO_0046685) (response to arsenic-containing substance), [GO:0031099](http://purl.obolibrary.org/obo/GO_0031099) (regeneration), [GO:0035458](http://purl.obolibrary.org/obo/GO_0035458) (cellular response to interferon-beta), [GO:0033030](http://purl.obolibrary.org/obo/GO_0033030) (negative regulation of neutrophil apoptotic process), [GO:0034122](http://purl.obolibrary.org/obo/GO_0034122) (negative regulation of toll-like receptor signaling pathway), [GO:0033033](http://purl.obolibrary.org/obo/GO_0033033) (negative regulation of myeloid cell apoptotic process), [GO:0046326](http://purl.obolibrary.org/obo/GO_0046326) (positive regulation of glucose import), [GO:0060732](http://purl.obolibrary.org/obo/GO_0060732) (positive regulation of inositol phosphate biosynthetic process), [GO:0048747](http://purl.obolibrary.org/obo/GO_0048747) (muscle fiber development), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0045123](http://purl.obolibrary.org/obo/GO_0045123) (cellular extravasation), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:2000343](http://purl.obolibrary.org/obo/GO_2000343) (positive regulation of chemokine (C-X-C motif) ligand 2 production), [GO:0055037](http://purl.obolibrary.org/obo/GO_0055037) (recycling endosome), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0036413](http://purl.obolibrary.org/obo/GO_0036413) (histone H3-R26 citrullination), [GO:0036414](http://purl.obolibrary.org/obo/GO_0036414) (histone citrullination), [GO:0035567](http://purl.obolibrary.org/obo/GO_0035567) (non-canonical Wnt signaling pathway), 

**Class expressions from DL-Learner:**

- Thing 57.86%
- [GO:0061687](http://purl.obolibrary.org/obo/GO_0061687) (detoxification of inorganic compound) 50.33%
- [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway) 50.33%
- [GO:0050851](http://purl.obolibrary.org/obo/GO_0050851) (antigen receptor-mediated signaling pathway) 50.33%
- [GO:0050787](http://purl.obolibrary.org/obo/GO_0050787) (detoxification of mercury ion) 50.33%
- [GO:0038096](http://purl.obolibrary.org/obo/GO_0038096) (Fc-gamma receptor signaling pathway involved in phagocytosis) 50.33%
- [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II) 50.33%
- [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway) 50.33%
- [GO:0002524](http://purl.obolibrary.org/obo/GO_0002524) (hypersensitivity) 50.33%
- [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II) 50.33%
- [GO:0002495](http://purl.obolibrary.org/obo/GO_0002495) (antigen processing and presentation of peptide antigen via MHC class II) 50.33%
- [GO:0002445](http://purl.obolibrary.org/obo/GO_0002445) (type II hypersensitivity) 50.33%
- [GO:0002438](http://purl.obolibrary.org/obo/GO_0002438) (acute inflammatory response to antigenic stimulus) 50.33%
- [GO:0001794](http://purl.obolibrary.org/obo/GO_0001794) (type IIa hypersensitivity) 50.33%
- [GO:0001788](http://purl.obolibrary.org/obo/GO_0001788) (antibody-dependent cellular cytotoxicity) 50.33%


